4.5 Review

Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines

Journal

JOURNAL OF DERMATOLOGY
Volume 41, Issue 1, Pages 43-49

Publisher

WILEY
DOI: 10.1111/1346-8138.12346

Keywords

adult T-cell leukemia; lymphoma; extranodal natural killer; T-cell lymphoma; guideline; interferon-gamma; mycosis fungoides; vorinostat

Categories

Funding

  1. Ministry of Health, Labor and Welfare: H21-Clinical Cancer Research-023 (chief researcher, Koichi Hirata)
  2. H23-Clinical Cancer Reseaarch-021 (chief researcher, Toshiki Watanabe)
  3. H23-Clinical Cancer Research-020

Ask authors/readers for more resources

The first Japanese edition of guidelines for management of cutaneous lymphoma was published jointly in 2009 by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) - Lymphoma Study Group; the guidelines were revised in 2011, and published in English in 2013. The JDA/JSCS guidelines are unique because they describe information and management practices for lymphomas specific to Asia, such as adult T-cell leukemia/lymphoma and extranodal natural killer/T-cell lymphoma, nasal type. In the present article, we have highlighted the essential points of management for cutaneous lymphomas in Asia. In order to complement the guidelines, we have added further information and our clinical experience of some currently available agents for cutaneous lymphomas in Japan.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available